Different Approaches for the Management of Post-dural Puncture Headache
NCT ID: NCT05253014
Last Updated: 2022-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2018-01-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intravenous Versus Intrathecal Dexamethazone on Postdural Puncture Headache
NCT04709029
Intrathecal Neostigmine for Prevention of PDPH
NCT03587441
Bupivacaine 0.125% Versus Bupivacaine 0.25% in Superficial Cervical Plexus Block for Tympanomastoid Surgeries in Adults
NCT06381401
Safety and Efficacy of Addition of Hyaluronidase to Lidocaine and Bupivacaine in Scalp Nerves Block in Elective Craniotomy Operations, Comparative Study
NCT03411330
Comparison Between Bilateral Infraorbital Block Versus Intranasal Bupivacaine in Transsphenoidal Pituitary Adenoma Resection
NCT05301634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lidocaine group
sphenopalatine ganglion block
block of the sphenopalatine ganglion using either lidocaine or bupivacaine to relief postdural puncture headache
bupivacaine group
sphenopalatine ganglion block
block of the sphenopalatine ganglion using either lidocaine or bupivacaine to relief postdural puncture headache
conservative group
paracetamol
intravenous paracetamol every 8 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sphenopalatine ganglion block
block of the sphenopalatine ganglion using either lidocaine or bupivacaine to relief postdural puncture headache
paracetamol
intravenous paracetamol every 8 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the patient underwent CS under spinal anesthesia
* The headache developed within 5 days after the dural puncture
* There is no different explanation for the headache
Exclusion Criteria
* history of nasal bleeding
* nasal polyp
* septal deviation
* local anesthetics reaction
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bahaa Mohammed Refaie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bahaa Mohammed Refaie
lecturer of anesthesia and ICu
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag faculty of medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.